The pivotal ABSORB III and Japan trials randomized patients with noncomplex coronary artery disease to Absorb bioresorbable vascular scaffolds (BVS) versus cobalt-chromium Xience everolimus-eluting stents (EES) (both Abbott Vascular, Santa… Click to show full abstract
The pivotal ABSORB III and Japan trials randomized patients with noncomplex coronary artery disease to Absorb bioresorbable vascular scaffolds (BVS) versus cobalt-chromium Xience everolimus-eluting stents (EES) (both Abbott Vascular, Santa Clara, California). Formal intravascular ultrasound (IVUS)
               
Click one of the above tabs to view related content.